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Abstract
Pharmacoepidemiology  analysis  of  efficacy  and  safety  of  antiepileptics  was  carried  out  in
children (3 months-18 years old) registered with municipal children's epilepsy services: 548
children in 2005, 718 - In 2007 and 32 - In 2011. We used remission lasting for 1 year or longer,
and 3 years or longer as primary effectiveness outcomes, and total number of people with
adverse effects as a safety outcome. We found no advantages of newer antiepileptics over the
older ones in terms of either efficacy or safety. Long-term follow up (more than 3 years) showed
higher treatment response rate in patients with childhood versus juvenile absence epilepsy. ©
2012 - IOS Press and the authors. All rights reserved.
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